Applies to Medicaid plans.
Covered with requirementsQualification pathways
You can qualify through any one of these.
CV Risk Reduction
All of:
- Confirmed diagnosis of cardiovascular disease
- Patient BMI ≥ 40 kg/m²
- Patient is participating in lifestyle modifications that support cardiovascular health
Documentation to bring
- Confirmation of cardiovascular disease diagnosis
- Baseline BMI documentation (≥ 40 kg/m²)
- Documentation of participation in lifestyle modifications supporting cardiovascular health
Quantity limits
- Two treatment attempts per lifetime (lifetime quantity limit)
Policy note: Lifetime quantity limit of two treatment attempts applies. Document is a partial excerpt from what appears to be the New York Medicaid (NYRx) DUR/PDL criteria document. Only the cv risk reduction indication for Wegovy is addressed in this excerpt. The BMI threshold of ≥ 40 kg/m² is notably higher than the FDA label threshold and typical commercial PA thresholds (27-30 kg/m²). Specific qualifying cardiovascular disease events are not enumerated in this excerpt. The standard PA fax form referenced is the New York Rx/Medicaid PA form.
Policy effective April 23, 2026 · verified June 3, 2026 · source: Nyrx Pdp Pdl · View policy document (PDF)